Delivery Order SPE2DB20D1004-SPE2DB23FF5M8
Award Date
3/29/23
Potential Completion Date
3/30/23
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,624.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024 and is a firm fixed-price delivery order. This award is not designated with a set-aside requirement, indicating open competition....
This federal contract award, identified as SPE2DB25D2207|SPE2DB25FQPTH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 mg tablets, a pharmaceutical product, and has a ceiling value of $17,776.50. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of October 31, 2024. It is not designated as a...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTBE7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $8,064.75 firm fixed-price delivery order contract is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of November 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM72X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,691.54, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV8EH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $12,283.25. This is a firm fixed-price delivery order contract with a final completion date of February 6, 2025. The contract does not have a set-aside designation,...
This federal contract award, with ID SPE2DB20D2200|SPE2DB24FW48U, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XIFAXAN 550 MG tablets. The contract has a ceiling value of $23,555.38 and an ultimate completion date of April 3, 2024. This is a delivery order contract, with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,561.49, is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award, valued at $4,348.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This is a Firm Fixed Price, Delivery Order contract with a completion date of July 17, 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,710.14, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside and was awarded through open competition....
This federal contract award, valued at $3,623.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a completion date of February 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...